Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$141M Buy
2,250,990
+9,376
+0.4% +$572K 0.47% 43
2016
Q3
$141M Buy
2,241,614
+43,483
+2% +$2.81M 0.48% 46
2016
Q2
$136M Buy
2,198,131
+15,261
+0.7% +$930K 0.49% 45
2016
Q1
$125M Sell
2,182,870
-332,953
-13% -$18.6M 0.46% 46
2015
Q4
$149M Sell
2,515,823
-164,802
-6% -$9.49M 0.56% 41
2015
Q3
$146M Buy
2,680,625
+77,062
+3% +$5.02M 0.58% 40
2015
Q2
$175M Buy
2,603,563
+25,809
+1% +$1.68M 0.68% 28
2015
Q1
$151M Buy
2,577,754
+7,250
+0.3% +$438K 0.6% 36
2014
Q4
$168M Buy
2,570,504
+80,928
+3% +$5.1M 0.64% 30
2014
Q3
$144M Buy
2,489,576
+383,093
+18% +$21.3M 0.62% 30
2014
Q2
$119M Sell
2,106,483
-168,940
-7% -$8.86M 0.54% 38
2014
Q1
$117M Buy
2,275,423
+96,905
+4% +$4.9M 0.52% 39
2013
Q4
$115M Sell
2,178,518
-101,595
-4% -$4.99M 0.51% 37
2013
Q3
$102M Sell
2,280,113
-920,002
-29% -$40.8M 0.49% 39
2013
Q2
$132M Buy
+3,200,115
New +$140M 0.61% 30

Other funds holding ABBV

BlackRock Japan's ABBV Position: Q4 2016 in Review

BlackRock Japan increased its AbbVie (ABBV) stake by 0.42% in Q4 2016, buying an estimated $572K and bringing the position to 2,250,990 shares worth $141M. The position accounts for 0.47% of the portfolio, ranked #43.

BlackRock Japan first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $175M in Q2 2015. 1,692 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • BlackRock Japan held 2,250,990 shares of AbbVie worth $141M as of Q4 2016.
  • BlackRock Japan bought 9,376 AbbVie shares in Q4 2016, an estimated $572K.
  • AbbVie made up 0.47% of BlackRock Japan's portfolio in Q4 2016, its #43 holding.
  • BlackRock Japan first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's AbbVie position peaked at $175M in Q2 2015.
  • 1,692 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.